首页> 外文期刊>Regulatory peptides. >Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides).
【24h】

Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides).

机译:骨髓调节肽(髓肽)的免疫纠正作用的特点。

获取原文
获取原文并翻译 | 示例
           

摘要

Myelopeptides (MPs) are low-molecular-weight immunoregulatory peptides of bone marrow origin. The peculiarities of their immunoregulatory effects are demonstrated with two of the six synthesized MPs, MP-1 (Phe-Leu-Gly-Phe-Pro-Thr) and MP-2 (Leu-Val-Val-Tyr-Pro-Trp). It is shown that MP action is directed to the damaged links of immunity. MP-1 enhances a decreased level of antibody production in cyclophosphamide (Cy)-treated mice, but does not influence the antibody formation in normal animals. MP-2 inhibits the tumor growth more in a tumor-bearing organism as the tumor size gets larger, insofar as MP-2 antitumor effect is concerned, by its ability to recover functional activity of T lymphocytes suppressed by tumor products. Selective immunocorrective effects of MPs are based on ligand-receptor interactions. Using FITC-labeled MP-1 and [3H]-labeled MP-2, specific binding of these peptides with appropriate cell populations is shown. The cytofluorimetric analysis revealed a target cell for MP-1-CD4(+) T lymphocyte (T helper). The data obtained suggest that MPs are endogenic immunoregulators which participate in the maintenance of immune homeostasis.
机译:骨髓肽(MPs)是骨髓来源的低分子量免疫调节肽。六个合成MP中的两个MP-1(Phe-Leu-Gly-Phe-Pro-Thr)和MP-2(Leu-Val-Val-Tyr-Pro-Trp)证明了其免疫调节作用的独特性。结果表明,MP动作是针对免疫力受损的环节。 MP-1增强了环磷酰胺(Cy)处理的小鼠中抗体产生的水平降低,但不影响正常动物中抗体的形成。随着肿瘤尺寸变大,就其MP-2抗肿瘤作用而言,MP-2通过其恢复被肿瘤产物抑制的T淋巴细胞的功能活性的能力而在肿瘤携带生物中更多地抑制肿瘤生长。 MP的选择性免疫纠正作用基于配体-受体相互作用。使用FITC标记的MP-1和[3H]标记的MP-2,显示了这些肽与适当细胞群的特异性结合。细胞荧光分析显示MP-1-CD4(+)T淋巴细胞(T辅助细胞)的靶细胞。获得的数据表明,MPs是内源性免疫调节剂,参与维持免疫稳态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号